Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Semi-synthetic conversion of paclitaxel to docetaxel

Inactive Publication Date: 2007-02-01
INNOVATIONAL HLDG LLC
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] The present invention provides a simple process for conversion of paclitaxel or a paclitaxel-containing material to its synthetic analog—docetaxel. Accordingly, one embodiment of the present invention provides a process for producing a taxane intermediate under mild conditions using a pure or partially purified paclitaxel or a paclitaxel analog as a starting material, the taxane intermediate can later be used as a precursor to docetaxel. The process comprises protecting a compound of Formula (I): wherein, R1 is alkyl, alkenyl or aryl; and X, Y and Z are the same or different and independently hydroxy or protected hydroxy. In particular, the process comprises: protecting one or more hydroxy groups at the C-2′, C-7 and C-10 positions of the taxane; and introducing a t-Boc group at the nitrogen of the amide group at the C-3′ position of the taxane to provide a C-2′, C-7, C-10 and N-t-Boc protected paclitaxel derivative, wherein the steps of protecting one or more hydroxy groups and introducing the t-Boc group comprises combining, in a one pot reaction, the taxane with a hydroxy protecting group and a t-Boc agent.
[0020] In addition, the present invention provides a simplified and efficient process for preparing docetaxel from an initial mixture of taxanes, wherein the initial mixture comprises paclitaxel and at least one additional taxane selected from the group of 10-deacetylbaccatin III, 9-dihydro-13-acetylbaccatin III, baccatin III, cephalomannine, 10-deacetyl taxol, 7-xylosyl taxol and 10-deacetyl-7-xylosyl taxol, the process comprising the steps of: protecting the hydroxy groups at the C-2′ and C-7 positions of paclitaxel; introducing a t-Boc group at the nitrogen of the amide group at the C-3′ position of paclitaxel to provide a protected paclitaxel derivative having an urea linkage at the C-3′ position; selectively removing the benzoyl group from the urea linkage to provide a protected docetaxel; and converting the protected docetaxel to docetaxel by removing the hydroxy-protecting groups at the C-7, C-2′ and C-10 positions, wherein the step of protecting the hydroxy groups at C-2′ and C-7 positions, and introducing a t-Boc group at the nitrogen site of the amide group of paclitaxel are carried out in a one pot reaction wherein the mixture containing paclitaxel is combined with a hydroxy protecting agent and a t-Boc agent; and wherein the step of selectively removing the benzoyl group comprises subjecting the protected paclitaxel derivative having the urea linkage to a first base.

Problems solved by technology

However, the above methods thus far developed involve subjects such as reaction under the conditions of extremely low temperatures, generation of diastereomers, use of asymmetry controlling agents, and the reaction under strongly alkaline conditions, which cause problems upon the industrialization thereof.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Semi-synthetic conversion of paclitaxel to docetaxel
  • Semi-synthetic conversion of paclitaxel to docetaxel
  • Semi-synthetic conversion of paclitaxel to docetaxel

Examples

Experimental program
Comparison scheme
Effect test

example 1

Protection of C-7, C-2′ and / or C-10 Hydroxy Groups in a One Pot Reaction

[0135] As shown in FIG. 1, to a stirred solution of paclitaxel or paclitaxel containing material, in an organic solvent, such as THF, at around low to room temperature under an argon atmosphere was treated with a hydroxy-protecting agent, such as Boc2O, dichloroacetyl chloride, acetyl chloride, TESCl or like reagents in the presence of a base, such as 4-(N,N-dimethylamino)pyridine or n-BuLi or a mixture of n-BuLi / Li-t-OBu or like bases. The reaction was stirred at this temperature for a period between 30 minutes to 2 hours until complete consumption of the starting materials, as evidenced by TLC.

[0136] Alternatively, to a stirred solution of paclitaxel or paclitaxel containing material, in an organic solvent, such as THF, at around low to room temperature under an argon atmosphere can be treated with a hydroxy-protecting agent such as ethyl vinyl ether, in the presence of a catalytic amount of p-toluenesulfoni...

example 2

Synthesis of Docetaxel

[0141] As further shown in FIG. 1, C-2′, C-7 and C-10 protected docetaxel was hydrolyzed using formic acid to remove the C-7 and / or C-10 t-Boc protecting group and then with a mixture of NaHCO3 / Na2CO3 / H2O2 to deprotect the C-2′ and / or C-10 acetate groups to yield docetaxel. In the event that the C-2′ protecting group is ethoxyethyl, the deprotection is carried out under acidic condition, such as in the presence of acetic acid. Detailed description of deprotection at the C-2′, C-7 and C-10 positions are described in U.S. patent application Ser. No. 10 / 790,622, which application is assigned to the assignee of the present invention and is incorporated herein by reference in its entirety.

example 3

Synthesis of the Primary Amine Derivative of Paclitaxel

Nitrosation

[0142] To a solution of paclitaxel (0.76 mmol) or a paclitaxel containing material in glacial acetic acid (2.5 ml) and acetic anhydride (5 ml) at 0° C. is added NaNO2 (7.6 mmol). The resulting solution can be stirred under argon at 0° C. for 16 h and then poured over ice and extracted with diethyl ether. The combined organic extracts can be washed with water, 5% Na2CO3, water and saturated NaCl and dried over MgSO4. The dry extracts can be filtered and then concentrated in vacuo, and the crude product is purified by column chromatography using mixtures of hexane-ethyl acetate to afford the pure product.

Hydrolysis

[0143] To the above solution in tetrahydrofuran is added a 1.0 N solution of lithium hydroxide. The solution was stirred for 12 h at room temperature. After the removal of tetrahydrofuran in vacuo, the basic aqueous residue can be acidified by the addition of 10% acetic acid and extracted with ether. Dry...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

A process is provided for the semi-synthesis of taxane derivatives useful in the preparation of docetaxel, in particular, the semi-synthesis of protected taxane derivatives in a one pot reaction of protecting the C-2′, C-7 and C-10 and introducing a t-Boc group at the nitrogen of the amide group at the C-3′ position in paclitaxel and subsequently conversion to docetaxel, and derivatives used therein.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a continuation of U.S. patent application Ser. No. 10 / 881,711 filed Jun. 29, 2004, now pending, which application is incorporated herein by reference in its entirety.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates to a semi-synthesis of taxane derivatives useful in the preparation of docetaxel, from pure or crude paclitaxel or related taxane starting material, in particular, the semi-synthesis of protected taxane derivatives in a one pot reaction and its conversion to docetaxel. [0004] 2. Description of the Related Art [0005] The taxane family of terpenes has received much attention in the scientific and medical community because the members of this family have demonstrated broad spectrum anti-leukemic and tumor-inhibitory activity. Docetaxel (1, Taxotere), a semi-synthetic analog, and paclitaxel (2, Taxol), a complex diterpene isolated from the bark of the Pacific yew...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D305/12C07D305/14
CPCC07D305/14
Inventor NAIDU, RAGINAFOO, SAMUEL SIANG KIANGXUE, BAO YUFAN, BO
Owner INNOVATIONAL HLDG LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products